HPV cervical infections and serological status in vaccinated and unvaccinated women - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Vaccine Année : 2020

HPV cervical infections and serological status in vaccinated and unvaccinated women

Carmen Lía Murall
  • Fonction : Auteur
Bastien Reyné
Claire Bernat
  • Fonction : Auteur
Vanina Boué
  • Fonction : Auteur
Sophie Grasset
  • Fonction : Auteur
Soraya Groc
  • Fonction : Auteur
Massilva Rahmoun
Noemi Bender
  • Fonction : Auteur
Marine Bonneau
  • Fonction : Auteur
Vincent Foulongne
Christelle Graf
  • Fonction : Auteur
Eric Picot
  • Fonction : Auteur
Marie-Christine Picot
Vincent Tribout
  • Fonction : Auteur
Tim Waterboer
  • Fonction : Auteur
Ignacio Bravo
Jacques Reynes
  • Fonction : Auteur
Michel Segondy
Nathalie Boulle
Samuel Alizon

Résumé

Understanding genital infections by Human papillomaviruses (HPVs) remains a major public health issue, especially in countries where vaccine uptake is low. We investigate HPV prevalence and antibody status in 150 women (ages 18 to 25) in Montpellier, France. At inclusion and one month later, cervical swabs, blood samples and questionnaires (for demographics and behavioural variables) were collected. Oncogenic, non-vaccine genotypes HPV51, HPV66, HPV53, and HPV52 were the most frequently detected viral genotypes overall. Vaccination status, which was well-balanced in the cohort, showed the strongest (protective) eect against HPV infections, with an associated odds ratio for alphapapillo-mavirus detection of 0.45 (95% condence interval: [0.22;0.58]). We also identied signicant eects of age, number of partners, body mass index, and contraception status on HPV detection and on coinfec-tions. Type-specic IgG serological status was also largely explained by the vaccination status. IgM seropositivity was best explained by HPV detection at inclusion only. Finally, we identify a strong signicant eect of vaccination on genotype prevalence, with a striking under-representation of HPV51 in vaccinated women. Variations in HPV prevalence correlate with key demographic and behavioural variables. The cross-protective eect of the vaccine against HPV51 merits further investigation.
Fichier principal
Vignette du fichier
main_medrxiv.pdf (351.12 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Commentaire : preprint from medRxiv

Dates et versions

hal-03001077 , version 1 (14-11-2020)
hal-03001077 , version 2 (28-03-2021)

Identifiants

Citer

Carmen Lía Murall, Bastien Reyné, Christian Selinger, Claire Bernat, Vanina Boué, et al.. HPV cervical infections and serological status in vaccinated and unvaccinated women. Vaccine, 2020, ⟨10.1016/j.vaccine.2020.10.078⟩. ⟨hal-03001077v1⟩
144 Consultations
222 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More